Search

H3K27me3 conditions chemotolerance in triple-negative breast cancer

4.5 (370) · $ 14.50 · In stock

H3K27me3 conditions chemotolerance in triple-negative breast cancer
H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

Expression analyses of hormono resistant tumors. A, IGF-IR and PR

Expression analyses of hormono resistant tumors. A, IGF-IR and PR

H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

Céline VALLOT, Group Leader, PhD, Institut Curie, Paris, UMR3244 -  Département de Recherche Translationnelle

Céline VALLOT, Group Leader, PhD, Institut Curie, Paris, UMR3244 - Département de Recherche Translationnelle

H3K27me3 conditions chemotolerance in triple-negative breast

H3K27me3 conditions chemotolerance in triple-negative breast

Single cell decoding of drug induced transcriptomic reprogramming

Single cell decoding of drug induced transcriptomic reprogramming

A low-input high resolution sequential chromatin

A low-input high resolution sequential chromatin

Tellurium-driven maple leaf-shaped manganese nanotherapeutics

Tellurium-driven maple leaf-shaped manganese nanotherapeutics

The loss of B7-H4 expression in breast cancer cells escaping from T cell  cytotoxicity contributes to epithelial-to-mesenchymal transition, Breast  Cancer Research

The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition, Breast Cancer Research

PDF) Challenges for Triple Negative Breast Cancer Treatment

PDF) Challenges for Triple Negative Breast Cancer Treatment